Releases

20606 items in section

Dermatologist-Backed Skincare Ousts Luxury Giants in AI Search Rankings

Drunk Elephant, La Roche-Posay, and SkinCeuticals are now the primary recommendations when consumers query AI engines for beauty advice, according to the 2026 AI Beauty Authority Index. This shift signals a decline for heritage luxury brands that rely on massive traditional advertising budgets to maintain market visibility.

Five Global Institutions Awarded 2026 EBSCO Solar Grants

Five libraries and academic institutions spanning three continents have been selected to share $300,000 in funding through the 2026 EBSCO Solar Grant program. The initiative aims to offset the costs of solar panel installations, allowing these organizations to lower operating expenses while advancing local sustainability and educational outreach efforts.

Footprints Floors Launches $10,000 Home Remodeling Giveaway

Homeowners who have completed projects with Footprints Floors or Footprints Bath and Tile now have a chance to secure $10,000 for their next renovation. The nationwide contest, running through September 22, 2026, shifts the focus from social media popularity to the personal stories behind professional home improvements.

Eight Libraries Honored with 2026 John Cotton Dana Awards

Eight public and academic libraries have earned the 2026 John Cotton Dana Award, securing $10,000 grants for creative outreach campaigns. Administered by the American Library Association’s Core division and EBSCO, the program celebrates its 80th anniversary by spotlighting projects ranging from viral social media stunts to regional literacy initiatives.

STIIIZY Data Breach Settlement Offers Up to $7,500 in Compensation

A court-approved settlement is moving forward for thousands of individuals affected by a 2024 data breach at STIIIZY, Inc. The agreement provides financial restitution and credit monitoring services for customers whose private health or identity information was compromised when the company's servers were infiltrated last October.

Neuro-Restoration Funding Set to Reach $435.9 Million by 2036

The global neuro-restoration venture market is shifting from speculative research to a high-stakes clinical sector, with projections estimating a climb from $44.7 million in 2025 to $435.9 million by 2036. Investors are increasingly bypassing unproven concepts in favor of technologies that demonstrate measurable functional recovery and regulatory viability.

AI Diagnostics Market Poised to Hit $9.7 Billion by 2033

The global market for artificial intelligence in diagnostics is set for a significant expansion, projected to reach $9.68 billion by 2033. According to data from Grand View Research, the sector will maintain a compound annual growth rate of 21.7% as healthcare systems scramble to integrate automated, high-speed disease detection.

Global NLP Market Projected to Reach $250 Billion by 2031

The global market for natural language processing is set for a massive expansion, projected to climb from $70.11 billion in 2026 to $249.97 billion by 2031. Driven by a 29% compound annual growth rate, this surge reflects the rapid integration of AI-driven language tools into core enterprise operations.

Republic Finance to be Acquired by J.C. Flowers-Led Group

A private investor group led by J.C. Flowers & Co., alongside Nowlake Technology, has reached a definitive agreement to acquire the consumer loan provider Republic Finance. The transaction, which marks the exit of majority owner CVC Capital Partners, is expected to close in the second half of 2026.

Elea and AXIA Launch Amazon's First AI Data Center in Belém

The Amazon region is set to host its first neutral AI data center as Elea Data Centers and AXIA Energia announce the BEL1 facility in Belém. Scheduled to launch in the second quarter of 2027, the project aims to leverage 100% renewable energy to support growing digital infrastructure demands.

Avantis Investors Hits $150 Billion Milestone in Under Seven Years

Growth at Avantis Investors has accelerated to a record $150 billion in assets under management, a threshold reached just six months after the firm hit the $100 billion mark. Since launching its inaugural strategy in September 2019, the American Century Investments subsidiary has expanded rapidly across global markets.

BoomerangFX and Web Marketing Clinic Partner to Scale AI in Europe

BoomerangFX is expanding its footprint across the UK and Europe through a new strategic partnership with The Web Marketing Clinic. By combining specialized aesthetic brand expertise with an AI-driven practice management platform, the collaboration aims to bridge the persistent gap between lead generation and clinical patient conversion.

BoomerangFX expands European reach through Web Marketing Clinic partnership

London-based aesthetic clinics are gaining a unified digital infrastructure as BoomerangFX appoints Web Marketing Clinic as its strategic channel partner for the UK and Europe. The collaboration merges high-end brand agency services with an AI-driven operating platform designed to automate patient conversion and practice management across the private-pay healthcare sector.

BoomerangFX and Web Marketing Clinic Partner to Scale AI in Aesthetics

BoomerangFX is expanding its footprint across the UK and Europe by appointing Web Marketing Clinic as a strategic channel partner. The collaboration integrates the agency’s creative expertise with BoomerangFX’s AI-driven software, aiming to bridge the gap between patient demand generation and clinical practice management for aesthetic and surgical providers.

Anivive Secures Full FDA Approval for Canine Lymphoma Drug Laverdia

The U.S. Food and Drug Administration has granted full approval to Laverdia, an oral treatment for canine lymphoma. This milestone marks the first time Anivive Lifesciences has successfully navigated its entire AI-enabled development cycle, from initial drug repurposing to final regulatory clearance for a veterinary therapy.

Curis Expands TakeAim CLL Study Sites and Secures Reverse Split Approval

Curis, Inc. has officially opened eleven clinical sites for its Phase 2 TakeAim CLL study, marking a significant step in testing emavusertib alongside zanubrutinib. Simultaneously, the company’s shareholders have approved a reverse stock split, a strategic move designed to help the firm regain compliance with Nasdaq’s minimum bid price requirements.

4,500 Massachusetts Nurses and Clinicians Set for Historic Strike

Beginning July 8, approximately 4,500 nurses and healthcare professionals across Mass General Brigham facilities will launch the largest strike in state history. The Massachusetts Nurses Association scheduled the walkout after months of stalled contract negotiations, citing unmet demands for competitive wages, staffing stability, and patient care protections.

Air Products Releases 2026 Sustainability Performance Data

Industrial gas giant Air Products has officially released its 2026 Sustainability Report, detailing the company's economic, environmental, and social performance metrics for fiscal year 2025. The publication offers a comprehensive look at how the Lehigh Valley-based firm is aligning its global operations with shifting energy and environmental standards.

NASA Veteran Frederick Gregory Joins Starfighters Space Advisory Board

Starfighters Space has appointed former NASA Deputy Administrator Frederick D. Gregory as the inaugural member of its new Strategic Advisory Board. The move signals a push for deeper credibility as the company scales its commercial Mach 2+ flight testing and develops its proprietary STARLAUNCH platform from Kennedy Space Center.

MGM Resorts Schedules Second Quarter 2026 Earnings Call

Investors will get a look at the mid-year financial performance of MGM Resorts International on July 29, 2026. The Las Vegas-based gaming giant plans to release its second quarter results after the market closes, followed by a live conference call to discuss the figures with analysts and stakeholders.

Lupin Secures FDA Tentative Approval for Enzalutamide Tablets

The U.S. Food and Drug Administration has granted tentative approval to Mumbai-based Lupin Limited for its generic version of Enzalutamide, a treatment typically prescribed for prostate cancer. This regulatory milestone allows the pharmaceutical firm to prepare for market entry as a bioequivalent alternative to Astellas Pharma’s Xtandi.

Helus Pharma Advances Depression Drug Trial Toward 2026 Readout

Helus Pharma has surpassed 86% enrollment in its Phase 3 APPROACH trial for HLP003, a candidate designed to treat major depressive disorder. With the study moving toward a topline data release in the fourth quarter of 2026, the company remains focused on validating its novel serotonergic agonist platform under FDA Breakthrough designation.

Baron MINI Rebrands as MINI of Shawnee Mission

The Merriam-based dealership formerly known as Baron MINI has officially transitioned to the name MINI of Shawnee Mission. The move, effective June 4, 2026, aligns the Kansas location with a nationwide branding initiative from parent company Group 1 Automotive, aimed at standardizing its retail network across the United States.

Servier showcases new pediatric glioma data at ISPNO 2026

At the International Symposium on Pediatric Neuro-Oncology in Sydney, Servier is presenting three-year follow-up data from the FIREFLY-1 study, highlighting the efficacy of tovorafenib in treating BRAF-altered pediatric low-grade glioma while addressing the critical role of caregiver-physician communication in long-term treatment outcomes.

Forestry Workers Lobby Capitol Hill to Protect Manufacturing Jobs

Eighty-five forest products workers descended on Washington this week, conducting over 500 meetings with lawmakers to demand policy shifts. Representing 53 mills across 23 states, the coalition argues that current regulatory pressures—from air quality standards to forest management—threaten the livelihoods of nearly one million American manufacturing employees.

Nano-X Investors Face August Deadline in Securities Class Action

Investors who held Nano-X Imaging securities between March 31, 2025, and April 17, 2026, face an August 11, 2026, deadline to seek the role of lead plaintiff in a federal class action lawsuit, as law firm Faruqi & Faruqi, LLP steps up its investigation into alleged corporate misconduct.

Anixa Biosciences Reports Progress in Breast and Ovarian Cancer Trials

Anixa Biosciences has unveiled promising clinical results for its two primary immunotherapy programs at the New York Academy of Sciences' Frontiers in Cancer Immunotherapy symposium, marking a significant milestone in the company’s ongoing collaborations with the Cleveland Clinic and Moffitt Cancer Center.

The Doctors Company Finalizes $1.3 Billion Acquisition of ProAssurance

The Doctors Company has finalized its $1.3 billion acquisition of ProAssurance Corporation, integrating the specialty insurer into its physician-led organization. By purchasing all outstanding shares at $25.00 apiece, the nation’s largest medical malpractice insurer now oversees a combined entity protecting over 200,000 healthcare professionals with $12 billion in total assets.

MADD Unites Across North America to Combat Impaired Driving at World Cup

As millions of fans descend on North America for the FIFA World Cup, MADD Canada and the U.S.-based MADD are launching a joint campaign to curb impaired driving. The organizations are urging supporters to prioritize safety by planning for sober transportation before kickoff, regardless of the match outcome.